0.45 CNY
577.83 M CNY
53.48 B CNY
665.23 M
About NANJING PHARMACEUTICAL COMPANY LIMITED
Sector
Industry
Headquarters
Nanjing
Website
Founded
1951
ISIN
CNE000000KV1
FIGI
BBG000BQF413
Nanjing Pharmaceutical Co., Ltd. engages in the service of pharmaceutical distribution. Its business involves in drug circulation, purchasing products from pharmaceutical manufacturers and then wholesale to distributors, hospitals, pharmacies or directly sold to consumers through retail. It focuses on pharmaceutical wholesale, retail, online business and third-party logistics services. The company was founded in 1951 and is headquartered in Nanjing, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 600713 is 5.18 CNY — it has decreased by −1.33% in the past 24 hours. Watch NANJING PHARMACEUTICAL COMPANY LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange NANJING PHARMACEUTICAL COMPANY LIMITED stocks are traded under the ticker 600713.
600713 stock has risen by 5.50% compared to the previous week, the last month showed zero change in price, over the last year NANJING PHARMACEUTICAL COMPANY LIMITED has showed a 2.17% increase.
600713 reached its all-time high on Jun 3, 2015 with the price of 20.50 CNY, and its all-time low was 0.87 CNY and was reached on Jul 7, 2005. View more price dynamics on 600713 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
600713 stock is 3.11% volatile and has beta coefficient of 0.98. Track NANJING PHARMACEUTICAL COMPANY LIMITED stock price on the chart and check out the list of the most volatile stocks — is NANJING PHARMACEUTICAL COMPANY LIMITED there?
Today NANJING PHARMACEUTICAL COMPANY LIMITED has the market capitalization of 6.72 B, it has increased by 2.31% over the last week.
Yes, you can track NANJING PHARMACEUTICAL COMPANY LIMITED financials in yearly and quarterly reports right on TradingView.
600713 net income for the last quarter is 130.56 M CNY, while the quarter before that showed 152.24 M CNY of net income which accounts for −14.24% change. Track more NANJING PHARMACEUTICAL COMPANY LIMITED financial stats to get the full picture.
Yes, 600713 dividends are paid annually. The last dividend per share was 0.16 CNY. As of today, Dividend Yield (TTM)% is 3.09%. Tracking NANJING PHARMACEUTICAL COMPANY LIMITED dividends might help you take more informed decisions.
NANJING PHARMACEUTICAL COMPANY LIMITED dividend yield was 3.31% in 2023, and payout ratio reached 35.79%. The year before the numbers were 2.73% and 29.47% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 10, 2024, the company has 4.90 K employees. See our rating of the largest employees — is NANJING PHARMACEUTICAL COMPANY LIMITED on this list?
Like other stocks, 600713 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NANJING PHARMACEUTICAL COMPANY LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NANJING PHARMACEUTICAL COMPANY LIMITED technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NANJING PHARMACEUTICAL COMPANY LIMITED stock shows the buy signal. See more of NANJING PHARMACEUTICAL COMPANY LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.